Abivax SA American Depositary Shares share price logo

Abivax SA American Depositary Shares

NASDAQ: ABVX

Mid Cap

$124.00

+6.87

(+5.87%)

as on

Abivax SA American Depositary Shares Stock Performance

as on May 6, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $119.70
    $125.36
    downward going graph

    3.47%

    Downside

    1.10%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.59
    $148.83
    downward going graph

    95.49%

    Downside

    20.02%

    Upside

    downward going graph

Abivax SA American Depositary Shares share price movements today

Previous Close
$117.13
Open
$124.91
Volume
1.1M
Day's Low - High
$119.70 - $125.36
52 Week Low - High
$5.59 - $148.83

Abivax SA American Depositary Shares Historical Returns

1 Month Return
-1.96 %
3 Month Return
-0.46 %
1 Year Return
+ 1635.26 %
3 Year Return
0 %
5 Year Return
0 %

Abivax SA American Depositary Shares Stock Fundamentals & Key Indicators

Check Abivax SA American Depositary Shares market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$9.3B

EPS (TTM)

-3.6374

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-245.0M

Revenue (TTM)

4.6M

Profit Margin

0.00%

Return On Equity TTM

-135.58%

Abivax SA American Depositary Shares vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Abivax SA American Depositary Shares with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$9.3BNANA0.00%
BUY$39.8B125.53%74.6712.55%
BUY$109.3B101.66%27.732.94%
NA$33.0BNA118.865.37%
BUY$73.5B42.22%17.1229.65%

Stock Returns calculator for Abivax SA American Depositary Shares Stock including INR - Dollar returns

The Abivax SA American Depositary Shares stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Abivax SA American Depositary Shares investment value today

Current value as on today

₹20,76,445

Returns

₹19,76,445

(+1.98K%)

Returns from Abivax SA American Depositary Shares Stock

₹17,37,037 (+1.74K%)

Dollar Impact

₹2,39,408 (+239.41%)

Analyst Recommendation on Abivax SA American Depositary Shares Stock

Based on 14 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 14 analysts, 85.71% of analysts recommend a 'BUY' rating for Abivax SA American Depositary Shares. Average target price of $155.2

Abivax SA American Depositary Shares Share Price Target

Get share price movements and forecasts by analysts on Abivax SA American Depositary Shares.

What analysts predicted

20.1%UPSIDE

Target Price

$155.2

Current Price

$124

Analyzed by

14 Analysts

Target

$155.20

Abivax SA American Depositary Shares target price $155.2, a slight upside of 20.1% compared to current price of $124. According to 14 analysts rating.

Abivax SA American Depositary Shares Stock’s Investor Sentiment and Interest

Search interest for Abivax SA American Depositary Shares Stock has decreased by -45% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-45% versus previous 30 day period

Abivax SA American Depositary Shares Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
2
2
-
3
-
7
-
2
-
-2
Gross Profit
2
2
-
3
-
7
-
2
-
-3
Operating Income
-39
-92
-44
-39
-50
-132
-47
-93
-80
-147
EBITDA
-39
-92
-
-39
-
-131
-
-93
-
-146
Interest Expense
14
5
2
0
4
1
4
7
4
20
Depreciation
-
-
0
0
0
0
0
0
0
0
Income Before Tax
-54
-98
-42
-40
-55
-94
-52
-100
-153
-219
Income Tax Expense
-2
-2
-
-
-
-
-
-
-
2
Net Income
-56
-104
-46
-43
-61
-98
-56
-100
-153
-222
Net Profit Margin
-2311.08%
-4118.10%
0.00%
-1203.04%
0.00%
-1278.61%
0.00%
-4996.73%
0.00%
11009.07%

Abivax SA American Depositary Shares Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
0
0
0
0
0
4
5
11
-
Gross Profit
-15
0
0
-31
-41
0
4
4
11
-1
Operating Income
-18
-14
-19
-33
-38
-41
-64
-127
-172
-240
EBITDA
-18
-13
-19
-33
-37
-38
-53
-133
-171
-239
Interest Expense
0
0
0
1
2
3
6
13
4
27
Depreciation
-
-
-
0
0
0
0
0
1
1
Income Before Tax
-17
-14
-19
-34
-40
-42
-74
-152
-176
-320
Income Tax Expense
-3
-2
-3
-4
-2
-4
-4
-4
-
2
Net Income
-15
-13
-17
-34
-45
-47
-64
-161
-184
-322
Net Profit Margin
-11266.14%
-112230.00%
-87905.56%
-1531700.00%
-59604.76%
-114735.14%
-1325.33%
-3197.14%
-1633.08%
0.00%

Abivax SA American Depositary Shares Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-95
-42
-40
-55
-94
-52
-100
-153
-222
Operating Cash Flow
-71
-34
-42
-35
-68
-33
-66
-71
-71
Investing Cash Flow
-8
-
13
-
1
-
1
-
3
Financing Cash Flow
222
21
40
-6
-12
-7
-8
603
603
Change in Cash
137
-10
-19
-41
-36
-40
60
528
528

Abivax SA American Depositary Shares Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-14
-19
-33
-38
-42
-60
-147
-176
-322
Operating Cash Flow
-8
-14
-27
-29
-45
-53
-100
-154
-155
Investing Cash Flow
0
0
0
0
-1
-12
-10
15
-13
Financing Cash Flow
2
10
24
49
78
32
340
28
531
Change in Cash
-5
-4
-3
19
31
-33
224
-107
389

Abivax SA American Depositary Shares News & Key Events

  • img

    Today's Timeline - 16 March

    Mon, 04:32 PM

    -

    Jefferies initiates Abivax with a buy rating, citing strong potential for obefazimod in inflammatory bowel disease market.

Insights on Abivax SA American Depositary Shares

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, ABVX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, ABVX stock has moved up by 1635.3%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 3 quarters, 7.39M → -2.01M (in $), with an average decrease of 136.4% per quarter

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 4 quarters, -52.37M → -222.05M (in $), with an average decrease of 63.1% per quarter

About Abivax SA American Depositary Shares

ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
OrganisationAbivax SA American Depositary Shares
Headquarters7-11 Boulevard Haussmann, Paris, France, 75009
IndustryBiotechnology
CEOMr. Marc M. P. de Garidel M.B.A.
E-voting on sharesClick here to vote

Key Management of Abivax SA American Depositary Shares

Name

Title

Kevin Shan Ph.D.

VP & Global Head of Biometrics

Mr. Marc M. P. de Garidel M.B.A.

CEO & Director

Ms. Ida Hatoum

Chief People & Compliance Officer

Chris Rabbat Ph.D.

VP & Global Head of Medical Affairs

Mr. Jerome Denis Ph.D.

Executive Vice President of Process Development & Manufacturing

Hema Keshava

Senior Vice President of Finance

Mary Mantock

Senior VP & Global Head of Regulatory Affairs

Mr. Didier Blondel

EVP, CFO & Board Secretary

Mr. Patrick Malloy

Senior Vice President of Investor Relations

Mr. Pierre Courteille M.B.A.

Chief Business Officer

FAQs

What is Abivax SA American Depositary Shares share price today?

Abivax SA American Depositary Shares share price today is $124 as on at the close of the market. Abivax SA American Depositary Shares share today touched a day high of $125.36 and a low of $119.7.

What is the 52 week high and 52 week low for Abivax SA American Depositary Shares share?

Abivax SA American Depositary Shares share touched a 52 week high of $148.83 on and a 52 week low of $5.59 on . Abivax SA American Depositary Shares stock price today i.e. is closed at $124,which is 16.68% down from its 52 week high and 2118.25% up from its 52 week low.

What is Abivax SA American Depositary Shares's market capitalisation today?

Abivax SA American Depositary Shares market capitalisation is $0.01T as on .

How to invest in Abivax SA American Depositary Shares Stock (ABVX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Abivax SA American Depositary Shares on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Abivax SA American Depositary Shares Shares that will get you 0.0121 shares as per Abivax SA American Depositary Shares share price of $124 per share as on May 6, 2026 at 1:29 am IST.

What is the minimum amount required to buy Abivax SA American Depositary Shares Stock (ABVX) from India?

Indian investors can start investing in Abivax SA American Depositary Shares (ABVX) shares with as little as ₹95.28 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.80 in Abivax SA American Depositary Shares stock (as per the Rupee-Dollar exchange rate as on ). Based on Abivax SA American Depositary Shares share’s latest price of $124 as on May 6, 2026 at 1:29 am IST, you will get 0.0806 shares of Abivax SA American Depositary Shares. Learn more about fractional shares .